Introduction -- Challenges of pharmaceutical development -- Challenges of the DoD biodefense acquisition system -- The changing national landscape for biodefense -- Recommendations -- Conclusion
Summary
The author examines the productivity of the Department of Defense's biodefense research program over the course of more than 35 years, coupled with changes in the global research environment since the events of September 11, 2001. Where the deployment of a biologic agent of mass destruction is largely an unpredictable risk, the outcome certainly could be catastrophic for an unprotected population. An urgent moral imperative is cast upon the federal government, then, to objectively assess the application and management of its biodefense research resources
Notes
Title from title screen (viewed Apr. 12, 2007)
"March 2007."
Bibliography
Includes bibliographical references (pages 34-38)
File Type
Electronic book
Notes
System requirements: Adobe Acrobat Reader
Mode of access: Internet from the SSI web site. Address as of 5/24/07: http://www.strategicstudiesinstitute.army.mil/pdffiles/PUB767.pdf; current access available via PURL
